Ard Elshifa M. E. Mohammed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ard Elshifa M. E. Mohammed has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Amany Mohamed Hamed
Chemistry Department, Faculty of Science, Sohag University, Sohag 82524, Egypt
2 shared publications Islam Ragab
Department of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia
2 shared publicationsAhmed Rh. Ahmed
Department of Pathology, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publicationAhmed S. Osman
Department of Biochemistry, Faculty of Veterinary Medicine, Sohag University, Sohag, Egypt
1 shared publicationAzza Ma. Abouelella
Department of Clinical Pharmacology, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publicationDalia A. Elbahy
Department of Clinical Pharmacology, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publication
Latest Publications
- Open Access
- 28 November 2024
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 11, 1470711
The ameliorative effect of chrysin on ovarian toxicity caused by methidathion in female rats
Introduction: Methidathion (MD) is commonly used in agriculture and has adverse effects on reproduction. Chrysin (CHR) has several advantageous properties, such as anti-inflammatory, anti-cancer, and antioxidant properties. The purpose of the current investigation was to assess CHR’s therapeutic efficacy in reducing ovarian toxicity brought on by MD.Methods: Twenty-four female rats were divided into four groups of six animals each. Group 1 served as a control, while group 2 rats received MD (5 mg/kg). Rats in Group 3 received CHR at a dose of 50 mg/kg. Rats in group 4 received treatment with CHR after MD intoxication.Results and Discussion: Our research revealed that MD significantly (p < 0.001) increased the levels of MDA, caspase-3, FSH, LH, CA-125, and TNF-α but significantly (p < 0.001) decreased the levels of SOD, GSH, E2, and progesterone when compared to the control and CHR groups. After receiving CHR therapy, damage induced by MD was significantly (p < 0.001) repaired.Conclusion: This study showed that CHR could mitigate the adverse effects that MD causes to the ovaries by decreasing oxidative stress, inflammation, and apoptosis; improving antioxidant status; and restoring the correct ratio of sex hormones.
- 28 November 2024
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 11, 1470711
Open AccessThe ameliorative effect of chrysin on ovarian toxicity caused by methidathion in female rats
Introduction: Methidathion (MD) is commonly used in agriculture and has adverse effects on reproduction. Chrysin (CHR) has several advantageous properties, such as anti-inflammatory, anti-cancer, and antioxidant properties. The purpose of the current investigation was to assess CHR’s therapeutic efficacy in reducing ovarian toxicity brought on by MD.Methods: Twenty-four female rats were divided into four groups of six animals each. Group 1 served as a control, while group 2 rats received MD (5 mg/kg). Rats in Group 3 received CHR at a dose of 50 mg/kg. Rats in group 4 received treatment with CHR after MD intoxication.Results and Discussion: Our research revealed that MD significantly (p < 0.001) increased the levels of MDA, caspase-3, FSH, LH, CA-125, and TNF-α but significantly (p < 0.001) decreased the levels of SOD, GSH, E2, and progesterone when compared to the control and CHR groups. After receiving CHR therapy, damage induced by MD was significantly (p < 0.001) repaired.Conclusion: This study showed that CHR could mitigate the adverse effects that MD causes to the ovaries by decreasing oxidative stress, inflammation, and apoptosis; improving antioxidant status; and restoring the correct ratio of sex hormones.